Sign In
Buy PGEN
$3.81
-0.0500 (-1.30%)
At Close: Jun 03, 2026
Hero or Zero? 3 High-Risk Penny Stocks to Make You Rich
06:40am, Friday, 19'th May 2023
High-risk penny stocks have long tempted investors with the potential for significant returns. However, it is crucial to acknowledge the inherent risks associated with these speculative investments.
7 High-Potential Penny Stocks in the Biotech Sector
01:56pm, Thursday, 04'th May 2023
Most of the biggest biotech stocks on the market started off as unknown penny stocks. Look at Axsome Therapeutics (NASDAQ: AXSM ), for example.
Precigen to Announce First Quarter 2023 Financial Results on May 10th
08:30am, Wednesday, 03'rd May 2023
GERMANTOWN, Md. , May 3, 2023 /PRNewswire/ -- Precigen, Inc. (Nasdaq: PGEN), a biopharmaceutical company specializing in the development of innovative gene and cell therapies to improve the lives of
Strong Small-Cap Insider Buys: Q1 2023
12:15am, Wednesday, 26'th Apr 2023
Strong Small-Cap Insider Buys: Q1 2023.
5 Penny Stocks To Watch Today; Is It Time To Buy?
02:27pm, Thursday, 20'th Apr 2023
Penny stocks to watch today. The post 5 Penny Stocks To Watch Today; Is It Time To Buy?
2 Unmatched Stocks Wall Street Thinks Will Soar 152% or More in the Next 2 Years
10:59am, Friday, 17'th Mar 2023 The Motley Fool
Biotechs are capable of making huge gains in short periods, and they often do.
Founders at These 7 Companies Are Loading Up on Their Stock. Should You?
12:42pm, Wednesday, 15'th Mar 2023
The Executive Vice President of the Dish Network (NASDAQ: DISH ) is Jim DeFranco. He also happens to be a co-founder of the satellite TV provider.
Here's Why Precigen, Inc. (PGEN) Is a Great 'Buy the Bottom' Stock Now
01:55pm, Tuesday, 14'th Mar 2023 Zacks Investment Research
Precigen, Inc. (PGEN) appears to have found support after losing some value lately, as indicated by the formation of a hammer chart. In addition to this technical chart pattern, strong agreement among
Here's Why Precigen, Inc. (PGEN) Is a Great 'Buy the Bottom' Stock Now
11:26am, Tuesday, 14'th Mar 2023
Precigen, Inc. (PGEN) appears to have found support after losing some value lately, as indicated by the formation of a hammer chart. In addition to this technical chart pattern, strong agreement among
5 Penny Stocks To Buy According To Analysts, Targets Up To 952%
04:35pm, Tuesday, 07'th Mar 2023 PennyStocks
Penny stocks to buy according to analysts in 2023
The post 5 Penny Stocks To Buy According To Analysts, Targets Up To 952% appeared first on Penny Stocks to Buy, Picks, News and Information | PennySto
5 Penny Stocks To Buy According To Analysts, Targets Up To 952%
11:35am, Tuesday, 07'th Mar 2023
Penny stocks to buy according to analysts in 2023 The post 5 Penny Stocks To Buy According To Analysts, Targets Up To 952% appeared first on Penny Stocks to Buy, Picks, News and Information | PennySto
Fate Therapeutics (FATE) Reports Q4 Loss, Tops Revenue Estimates
10:15pm, Tuesday, 28'th Feb 2023 Zacks Investment Research
Fate Therapeutics (FATE) delivered earnings and revenue surprises of 32.56% and 124.91%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?
3 Penny Stocks The Insiders Are Buying
06:01am, Tuesday, 28'th Feb 2023
Penny stocks come with many risks, but with those risks come the potential for great rewards. While there is no guarantee which penny stocks will deliver those rewards, following the insiders is 1 way
BioMarin Pharmaceutical (BMRN) Q4 Earnings Lag Estimates
10:35pm, Monday, 27'th Feb 2023 Zacks Investment Research
BioMarin (BMRN) delivered earnings and revenue surprises of -7.69% and 0.69%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?
Ultragenyx (RARE) Reports Q4 Loss, Tops Revenue Estimates
10:15pm, Thursday, 16'th Feb 2023 Zacks Investment Research
Ultragenyx (RARE) delivered earnings and revenue surprises of -6.40% and 0.27%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?
